Sinopharm vaccines up to 78% effective, new study from prestigious American magazine – economic, financial and business news

the vaccines from Chinese laboratory Sinopharm managed to contain the Covid-19, according to a study published in the Journal of the American Medical Association (JAMA, for its acronym in English) a prestigious American medical journal.

This is the first time that the detailed results of a trial at an advanced stage of a chinese vaccine in the scientific literature.

the two inactivated virus vaccines developed by Sinopharm (one with the HBO2 strain or BBIBP-CorV to acquire the Argentina, developed by the Beijing Institute of Biologics, and WIV04 developed with the strain of Wuhan), stop symptomatic infections in 78.1% and 72.8% respectively, coinciding with what was announced by the state pharmacy.

Coronavirus vaccines: how long does protection last after receiving them

In the study published by JAMA they participated 40,832 volunteers of United Arab Emirates, Bahrin, Egypt Yes Jordan. They were divided equally into three groups and received two vaccine dose, three weeks apart, or a placebo. Two weeks after the second injection, infections developed in 26 people who received the vaccine called WIV04, of whom 21 received the vaccine. vaccine known as HBO2 and 95 who received a placebo injection.

None of the volunteers who received the vaccine active has developed an eserious illness, compared to two of those who received the placebo. The results were originally sent to JAMA March 17, according to the Sinopharm, China National Biotec Group, that’s a statement. The book was accepted for publication on May 12.

WHO approved Chinese vaccine to be manufactured in Argentina

However, the published study found some trial limitations of vaccine. The proof was very biased towards men, which represented almost 85% of the participants. Less than 2% were 60 years or older and the majority were in good health. Therefore, there is little evidence on thefficiency Yes security between the women, pregnant, elderly and the people with underlying illnesses.

The World Health Organization (WHO) authorized one of the Sinopharm Covid vaccines earlier this month, paving the way for wider dissemination around the world through the mechanism Covax which gives access to safe and effective vaccines.

Why is the most vaccinated country in the world facing a worse epidemic than India’s?

The key details of another Sinovac vaccine They have been published in preprinted form, without formal peer review or publication. This vaccine has not yet received the green light from the WHO, although more than 380 million doses have been distributed worldwide.

the chinese vaccines, including those of Sinopharm Yes Sinovacformed the backbone of vaccine deployment by Developing countries. Vaccinations have come under scrutiny and their manufacturers have come under fire for share data adequate on the safety and efficacy of injections.

The lack of transparency has fueled doubts about the ability of the vaccines to contain the Covidespecially after cases continued to increase in countries like Seychelles Yes Chile, who used them to vaccinate a considerable part of their population.